EUVIMEDEUVIMED entdecken
Open Access

Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome

Wei Wang iD, Jinyou Li, Siyuan Cui, Jiayu Li iD, Xianlong Ye, Zhe Wang, Tingting Zhang, Xuan Jiang, Yulin Kong, Xin Chen, Yong Q Chen iD, Shenglong Zhu iD

Science Advances · 2024

DOI: 10.1126/sciadv.adj7813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Wei Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Metabolic Syndrome, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic syndrome (MetS) is closely associated with an increased risk of dementia and cognitive impairment, and a complex interaction of genetic and environmental dietary factors may be implicated. Free fatty acid receptor 4 (Ffar4) may bridge the genetic and dietary aspects of MetS development. However, the role of Ffar4 in MetS-related cognitive dysfunction is unclear. In this study, we found that Ffar4 expression is down-regulated in MetS mice and MetS patients with cognitive impairment. Conventional and microglial conditional knockout of Ffar4 exacerbated high-fat diet (HFD)–induced cognitive dysfunction and anxiety, whereas microglial Ffar4 overexpression improved HFD-induced cognitive dysfunction and anxiety. Mechanistically, we found that microglial Ffar4 regulated microglial activation through type I interferon signaling. Microglial depletion and NF-κB inhibition partially reversed cognitive dysfunction and anxiety in microglia-specific Ffar4 knockout MetS mice. Together, these findings uncover a previously unappreciated role of Ffar4 in negatively regulating the NF-κB–IFN-β signaling and provide an attractive therapeutic target for delaying MetS-associated cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionMetabolic SyndromeReceptors, G-Protein-CoupledAnimalsHumansMiceMice, KnockoutMicrogliaNF-kappa BSignal Transduction

Substanzen

NF-kappa BFFAR4 protein, mouseReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Wuxi School of Medicine, Jiangnan University, Wuxi 214000, China.
  • Affiliated Hospital of Jiangnan University, Wuxi 214122, China.
  • Jiangnan University Medical Center, Wuxi 214002, China.
  • Ganjiang Chinese Medicine Innovation Center, Nanchang 330000, China.

ORCID-Profile: Wei Wang, Jiayu Li, Yong Q Chen, Shenglong Zhu

Zitieren

APA

Wang, W., Li, J., Cui, S., Li, J., Ye, X., Wang, Z., Zhang, T., Jiang, X., Kong, Y., Chen, X., Chen, Y. Q., & Zhu, S. (2024). Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome. Science Advances. https://doi.org/10.1126/sciadv.adj7813

Vancouver

Wang W, Li J, Cui S, Li J, Ye X, Wang Z, et al. Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome. Science Advances. 2024. doi:10.1126/sciadv.adj7813

BibTeX
@article{Wang2024,
  author = {Wang, Wei and Li, Jinyou and Cui, Siyuan and Li, Jiayu and Ye, Xianlong and Wang, Zhe and Zhang, Tingting and Jiang, Xuan and Kong, Yulin and Chen, Xin and Chen, Yong Q and Zhu, Shenglong},
  title = {Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adj7813}
}
Kostenlos starten →